BRIEF published on 03/08/2025 at 15:20, 1 year 7 months ago Protagonist Therapeutics Unveils Promising Results for Icotrokinra in Psoriasis Treatment Clinical Trials Protagonist Therapeutics Plaque Psoriasis Icotrokinra Treatment Efficacy
BRIEF published on 03/08/2025 at 15:20, 1 year 7 months ago Protagonist Therapeutics dévoile des résultats prometteurs pour l'icotrokinra dans le traitement du psoriasis Essais Cliniques Thérapeutique Protagoniste Icotrokinra Psoriasis En Plaques Efficacité Du Traitement
BRIEF published on 03/08/2025 at 00:59, 1 year 7 months ago Rektron Group's Artis Finance Subsidiary Enters Administration Administration Financial Stability Trade Operations Rektron Group Artis Finance
BRIEF published on 03/08/2025 at 00:59, 1 year 7 months ago La filiale Artis Finance du groupe Rektron est placée sous administration judiciaire Administration Stabilité Financière Operations Commerciales Groupe Rektron Artis Finance
BRIEF published on 03/07/2025 at 22:55, 1 year 7 months ago Carbeeza Inc. Appoints Tim Maddigan as New Director Artificial Intelligence Board Appointment Automotive Software Carbeeza Tim Maddigan
BRIEF published on 03/07/2025 at 22:55, 1 year 7 months ago Carbeeza Inc. nomme Tim Maddigan au poste de nouveau directeur Intelligence Artificielle Nomination Au Conseil D'administration Logiciel Automobile Carbeeza Tim Maddigan
BRIEF published on 03/07/2025 at 22:10, 1 year 7 months ago Organto Foods Reinstate Trading on TSX Venture Exchange TSX Venture Exchange Financial Statements Delay Organto Foods Convertible Debt Trading Reinstatement
BRIEF published on 03/07/2025 at 22:10, 1 year 7 months ago Organto Foods rétablit sa cotation à la Bourse de croissance TSX Bourse De Croissance TSX Dette Convertible Aliments Organto Retard Dans La Publication Des États Financiers Rétablissement Du Commerce
BRIEF published on 03/07/2025 at 21:19, 1 year 7 months ago Brockhaus Technologies Reports Preliminary 2024 Financial Results EBITDA Revenue Growth Preliminary Results 2025 Outlook Bike2Future
BRIEF published on 03/07/2025 at 21:19, 1 year 7 months ago Brockhaus Technologies publie ses résultats financiers préliminaires pour 2024 EBITDA Résultats Préliminaires Croissance Des Revenus Perspectives 2025 Vélo2Future
Published on 10/23/2026 at 02:20, 13 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 3 hours 3 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 4 hours 3 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 10 hours 33 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 12 hours 3 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 01:55, 38 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 4 hours 23 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 6 hours 33 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 6 hours 48 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 7 hours 48 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:00, 8 hours 33 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 8 hours 33 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 8 hours 33 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 8 hours 33 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 8 hours 33 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
